# DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

> **NCT07717437** · — · RECRUITING · sponsor: **Maastricht University Medical Center** · enrollment: 350 (estimated)

## Conditions studied

- Liver Cancer
- Liver Metastases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07717437
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-16
- **Primary completion:** 2027-11-30
- **Final completion:** 2032-11-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717437, "DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*